BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15269981)

  • 41. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial supernatants elevate glucose-dependent insulin secretion in rat pancreatic INS-1 line and islet β-cells via PI3K/AKT signaling.
    Ramenzoni LL; Zuellig RA; Hussain A; Lehmann R; Heumann C; Attin T; Schmidlin PR
    Mol Cell Biochem; 2019 Feb; 452(1-2):17-27. PubMed ID: 30039349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
    Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
    Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells.
    Briaud I; Dickson LM; Lingohr MK; McCuaig JF; Lawrence JC; Rhodes CJ
    J Biol Chem; 2005 Jan; 280(3):2282-93. PubMed ID: 15537654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway.
    Hirashima Y; Tsuruzoe K; Kodama S; Igata M; Toyonaga T; Ueki K; Kahn CR; Araki E
    J Endocrinol; 2003 Nov; 179(2):253-66. PubMed ID: 14596677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
    Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
    Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
    Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
    Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1.
    Kriauciunas KM; Myers MG; Kahn CR
    Mol Cell Biol; 2000 Sep; 20(18):6849-59. PubMed ID: 10958681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like growth factor-I-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2.
    Zhang Q; Berggren PO; Hansson A; Tally M
    J Endocrinol; 1998 Mar; 156(3):573-81. PubMed ID: 9582514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function.
    Paz K; Liu YF; Shorer H; Hemi R; LeRoith D; Quan M; Kanety H; Seger R; Zick Y
    J Biol Chem; 1999 Oct; 274(40):28816-22. PubMed ID: 10497255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation.
    Avram D; Ranta F; Hennige AM; Berchtold S; Hopp S; Häring HU; Lang F; Ullrich S
    Cell Physiol Biochem; 2008; 21(5-6):455-62. PubMed ID: 18453753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.
    Gills JJ; Lopiccolo J; Tsurutani J; Shoemaker RH; Best CJ; Abu-Asab MS; Borojerdi J; Warfel NA; Gardner ER; Danish M; Hollander MC; Kawabata S; Tsokos M; Figg WD; Steeg PS; Dennis PA
    Clin Cancer Res; 2007 Sep; 13(17):5183-94. PubMed ID: 17785575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes.
    Matsumoto M; Ogawa W; Teshigawara K; Inoue H; Miyake K; Sakaue H; Kasuga M
    Diabetes; 2002 Jun; 51(6):1672-80. PubMed ID: 12031952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
    Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
    Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Akt signals upstream of L-type calcium channels to optimize insulin secretion.
    Cui X; Yang G; Pan M; Zhang XN; Yang SN
    Pancreas; 2012 Jan; 41(1):15-21. PubMed ID: 21792084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling.
    Liberman Z; Eldar-Finkelman H
    J Biol Chem; 2005 Feb; 280(6):4422-8. PubMed ID: 15574412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
    Conejo R; Lorenzo M
    J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1.
    Peschke E; Mühlbauer E; Musshoff U; Csernus VJ; Chankiewitz E; Peschke D
    J Pineal Res; 2002 Sep; 33(2):63-71. PubMed ID: 12153439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.